Detection of a wide variety of human and veterinary fluoroquinolone antibiotics in municipal wastewater and wastewater-impacted surface water

Journal of Pharmaceutical and Biomedical Analysis

Volumn 106, Issue , 2015, Pages 136-143

  He, Ke ^a   Soares, Ana Dulce ^a   Adejumo, Hollie ^a   McDiarmid, Melissa ^b   Squibb, Katherine ^b   Blaney, Lee ^a  

^a Baltimore County   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Ciprofloxacin; Fluoroquinolones; Ofloxacin; Wastewater

Indexed keywords

CIPROFLOXACIN; DIFLOXACIN; ENROFLOXACIN; FLEROXACIN; GATIFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORDIFLOXACIN; NORFLOXACIN; OFLOXACIN; ORBIFLOXACIN; PHOSPHORUS; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SURFACE WATER; VETERINARY DRUG; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; WASTE WATER; WATER POLLUTANT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BIOCHEMICAL OXYGEN DEMAND; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENCY; ENVIRONMENTAL IMPACT; ESCHERICHIA COLI; HUMAN; LIMIT OF DETECTION; MUNICIPAL SOLID WASTE; NONHUMAN; PRIORITY JOURNAL; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER QUALITY; WATER SAMPLING; ANALYSIS; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; PROCEDURES; WASTE WATER; WATER MANAGEMENT; WATER POLLUTANT;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL OXYGEN DEMAND ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FLUOROQUINOLONES; HUMANS; PHOSPHORUS; VETERINARY DRUGS; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84923591839     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.11.020     Document Type: Article

References (43)

1. Bottoni P., Caroli S., Caracciolo A.B. Pharmaceuticals as priority water contaminants. Toxicol. Environ. Chem. 2010, 92:549-565.
2. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 1985, 37:1-12.
3. Rogers I.H., Birtwell I.K., Kruzynski G.M. Organic extractables in municipal wastewater, Vancouver, British Columbia. Water Pollut. Res. J. Can. 1986, 21:187-204.
4. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
5. Quirós L., Céspedes R., Lacorte S., Viana P., Raldúa D., Barcelò D., Piña B. Detection and evaluation of endocrine-disruption activity in water samples from Portuguese rivers. Environ. Toxicol. Chem. 2005, 24:389-395.
6. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
7. Cromwell G.L. Antimicrobial and promicrobial agents. Swine Nutr. 2001, 2:401-426.
8. NRC The Use of Drugs in Food Animals: Benefits and Risks 1999, The National Academies Press.
9. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment a review. Environ. Technol. 2001, 22:1383-1394.
10. Tölgyesi Á., Verebey Z., Sharma V.K., Kovacsics L., Fekete J. Simultaneous determination of corticosteroids, androgens, and progesterone in river water by liquid chromatography-tandem mass spectrometry. Chemosphere 2010, 78:972-979.
11. Robinson A.A., Belden J.B., Lydy M.J. Toxicity of fluoroquinolone antibiotics to aquatic organisms. Environ. Toxicol. Chem. 2005, 24:423-430.
12. Swenson D. Going green: helping hospitals be friendlier to the environment. Pharmacy Times 2011.
13. Copper C., Hanna S., Batni R., Bhattacharyya T., Shull B. EPA inaction in identifying hazardous waste pharmaceuticals may result in unsafe disposal 2012, US Environmental Protection Agency, Office of Inspector General.
14. NCCLS Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard 2004, NCCLS, Wayne, Pennsylvania, USA. 6th ed.
15. von Sperling M., de Lemos Chernicharo C.A. Biological Wastewater Treatment in Warm Climate Regions 2005, IWA Publishing, London, UK.
16. Tchobanoglous G., Burton F.L., Stensel H.D. Metcalf, Eddy, Wastewater Engineering: Treatment and Reuse 2003, McGraw-Hill Education, Boston, USA.
17. He K., Blaney L. Systematic optimization of an SPE with HPLC-FLD method for fluoroquinolone detection in wastewater. J. Hazard. Mater. 2014, (in press).
18. Golet E.M., Alder A.C., Hartmann A., Ternes T.A., Giger W. Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal. Chem. 2001, 73:3632-3638.
19. Nakata H., Kannan K., Jones P.D., Giesy J.P. Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection. Chemosphere 2005, 58:759-766.
20. Lara F.J., del Olmo-Iruela M., García-Campaña A.M. On-line anion exchange solid-phase extraction coupled to liquid chromatography with fluorescence detection to determine quinolones in water and human urine. J. Chromatogr. A 2013, 1310:91-97.
21. Ding C., He J. Effect of antibiotics in the environment on microbial populations. Appl. Microbiol. Biotechnol. 2010, 87:925-941.
22. Andersson D.I., Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 2014, 12:465-478.
23. Zhou L.-J., Ying G.-G., Liu S., Zhao J.-L., Yang B., Chen Z.-F., Lai H.-J. Occurrence and fate of eleven classes of antibiotics in two typical wastewater treatment plants in South China. Sci. Total Environ. 2013, 452-453:365-376.
24. Xu W., Yan W., Li X., Zou Y., Chen X., Huang W., Miao L., Zhang R., Zhang G., Zou S. Antibiotics in riverine runoff of the Pearl River Delta and Pearl River Estuary, China: Concentrations, mass loading and ecological risks. Environ. Pollut. 2013, 182:402-407.
25. Gibs J., Heckathorn H.A., Meyer M.T., Klapinski F.R., Alebus M., Lippincott R.L. Occurrence and partitioning of antibiotic compounds found in the water column and bottom sediments from a stream receiving two wastewater treatment plant effluents in Northern New Jersey, 2008. Sci. Total Environ. 2013, 458-460:107-116.
26. Leung H.W., Minh T.B., Murphy M.B., Lam J.C.W., So M.K., Martin M., Lam P.K.S., Richardson B.J. Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environ. Int. 2012, 42:1-9.
27. Balfour J., Todd P., Peters D. Fleroxacin. Drugs 1995, 49:794-850.
28. FDA Avelox (moxifloxacin hydrochloride) IV label, Accessdata FDA, NDA 021085 1999.
29. Wise R. A review of the clinical pharmacology of moxifloxacin, a new 8-methoxyquinolone, and its potential relation to therapeutic efficacy. Clin. Drug Investig. 1999, 17:365-387.
30. Jia A., Wan Y., Xiao Y., Hu J. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Res. 2012, 46:387-394.
31. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 2012, 86:665-671.
32. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
33. Boehringer Difloxacin hydrochloride product label information [package insert] 2010, Boehringer Ingelheim Vetmedica, Inc., Fort Dodge, IA.
34. Intervet Orbax (orbifloxacin) product label information [package insert] 2010, Intervet Inc., Friesoythe, Germany.
35. Dorival-García N., Zafra-Gómez A., Navalón A., González J., Vílchez J.L. Removal of quinolone antibiotics from wastewaters by sorption and biological degradation in laboratory-scale membrane bioreactors. Sci. Total Environ. 2013, 442:317-328.
36. Li B., Zhang T. Biodegradation and adsorption of antibiotics in the activated sludge process. Environ. Sci. Technol. 2010, 44:3468-3473.
37. Wammer K.H., Korte A.R., Lundeen R.A., Sundberg J.E., McNeill K., Arnold W.A. Direct photochemistry of three fluoroquinolone antibacterials: Norfloxacin, ofloxacin, and enrofloxacin. Water Res. 2013, 47:439-448.
38. 2 processes. Proceedings of the Water Environment Federation Technical Exhibition and Conference 2013.
39. Dodd M.C., Kohler H.P.E., von Gunten U. Oxidation of antibacterial compounds by ozone and hydroxyl radical: elimination of biological activity during aqueous ozonation processes. Environ. Sci. Technol. 2009, 43:2498-2504.
40. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
41. McClellan K., Halden R.U. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA national sewage sludge survey. Water Res. 2010, 44:658-668.
42. Gottschall N., Topp E., Metcalfe C., Edwards M., Payne M., Kleywegt S., Russell P., Lapen D.R. Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field. Chemosphere 2012, 87:194-203.
43. ChemAxon,. Accessed 26.06.13, 2013. http://www.chemicalize.org/.